Publication | Open Access
Evaluation of the Cost Per Patient Achieving Treatment Targets with Oral Semaglutide: A Short-Term Cost-Effectiveness Analysis in the United States
24
Citations
19
References
2019
Year
Novo Nordisk A/S.
| Year | Citations | |
|---|---|---|
Page 1
Page 1